Ritolukast
Ritolukast (Wy-48252) is an orally bioavailable leukotriene receptor antagonist that selectively blocks LTD4 and LTE4. It potently inhibits aerosol LTD4-induced bronchoconstriction in guinea pigs with an ID50 of 0.5 mg/kg, making it a useful research tool for studying asthma pathophysiology in vivo.
Product Specifications
CAS Number
111974-60-8
Field of Research
Pharmacology & Drug Discovery
Smiles
C (OC1=CC (NS (C (F) (F) F) (=O) =O) =CC=C1) C2=NC3=C (C=C2) C=CC=C3
Molecular Formula
C17H13F3N2O3S
Molecular Weight
382.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A04499-2-APC 100 µg/Vial
Anti-RPL22 Antibody Picoband® APC Conjugated
Sign In for Pricing
View Details ![Rabbit Polyclonal SCO2 Antibody [Biotin]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
209502-01 20 µL
AMPk alpha, phosphorylated (S172) (AMP-activated protein kinase alpha, AMPK, AMPKa1, MGC33776, MGC57364, PRKAA1) discontinued
Sign In for Pricing
View Details 209502-02 100 µL
AMPk alpha, phosphorylated (S172) (AMP-activated protein kinase alpha, AMPK, AMPKa1, MGC33776, MGC57364, PRKAA1) discontinued
Sign In for Pricing
View Details